XML 38 R9.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash Flows from Operating Activities:      
Net (Loss) Income $ (90,494) $ 1,720,716 $ (142,077)
Adjustments to Reconcile Net (Loss) Income to Net Cash Provided by Operating Activities:      
Depreciation, Depletion and Amortization 485,754 433,586 461,215
Amortization of Deferred Financing Costs 11,345 9,275 8,456
Stock-Based Compensation 20,091 20,235 16,375
Gain on Asset Sales and Abandonments, net (24,715) (132,372) (8,984)
Loss on Debt Extinguishment 7,043 0 22,953
Loss (Gain) on Commodity Derivative Instruments 172,405 (1,928,652) 2,663,775
Loss (Gain) on Other Derivative Instruments 1,099 3,463 (10,348)
Net Cash Received (Paid) in Settlement of Commodity Derivative Instruments 307,939 79,523 (1,735,115)
Deferred Income Taxes (33,869) 497,432 (76,058)
Other 1,345 (1,967) 5,588
Changes in Operating Assets:      
Accounts and Notes Receivable (59,996) 222,751 (20,338)
Supplies Inventories 5,274 7,310 (21,008)
Recoverable Income Taxes 0 0 72
Prepaid Expenses (675) 1,227 (252)
Changes in Other Assets (47,084) 75 21,499
Changes in Operating Liabilities:      
Accounts Payable (4,194) (55,309) 53,772
Accrued Interest 1,585 7,483 710
Other Operating Liabilities 21,000 (67,140) (267)
Changes in Other Liabilities 41,926 (3,048) (4,954)
Net Cash Provided by Operating Activities 815,779 814,588 1,235,014
Cash Flows from Investing Activities:      
Capital Expenditures (540,332) (679,404) (565,754)
Proceeds from Asset Sales 60,734 170,027 37,460
Investment in Equity Affiliates (4,871) 0 0
Net Cash Used in Investing Activities (484,469) (509,377) (528,294)
Cash Flows from Financing Activities:      
Payments on Long-Term Notes (356,504) 0 (385,719)
Payments on Other Debt (2,409) (1,627) (665)
Proceeds from Issuance of Common Stock 2,689 1,760 1,197
Shares Withheld for Taxes (18,279) (9,500) (5,852)
Purchases of Common Stock (184,203) (319,866) (565,125)
Debt Issuance and Financing Fees (15,274) (356) (3,250)
Net Cash Used in Financing Activities (276,680) (326,089) (688,964)
Net Increase (Decrease) in Cash and Cash Equivalents 54,630 (20,878) 17,756
Cash and Cash Equivalents at Beginning of Period 443 21,321 3,565
Cash, Cash Equivalents, and Restricted Cash at End of Period 55,073 443 21,321
CNXM Revolving Credit Facility      
Cash Flows from Financing Activities:      
Proceeds from revolving credit facility borrowings 265,250 333,575 343,900
Repayments of revolving credit facility borrowings (354,350) (382,125) (375,200)
CNX Revolving Credit Facility      
Cash Flows from Financing Activities:      
Proceeds from revolving credit facility borrowings 1,134,500 1,588,350 3,332,875
Repayments of revolving credit facility borrowings (1,143,100) (1,536,300) (3,524,875)
CNX Senior Notes      
Cash Flows from Financing Activities:      
Proceeds from Issuance of CNX Senior Notes $ 395,000 $ 0 $ 493,750